CLINICAL_TRIALS
trial_result
· 2022-03-16
Clinical Trial Update: RhDNase and Biodistribution of PMN Serine Proteases in Cystic Fibrosis Sputum [Phase 4]
Summary
Phase 4 trial update evaluating RhDNase and biodistribution of PMN serine proteases in cystic fibrosis sputum has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hospital, Tours | Conditions: Cystic Fibrosis | Phase 4 | Status: COMPLETED